文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

作者信息

Garnero P, Piperno M, Gineyts E, Christgau S, Delmas P D, Vignon E

机构信息

Inserm Research Unit 403, Lyon, France.

出版信息

Ann Rheum Dis. 2001 Jun;60(6):619-26. doi: 10.1136/ard.60.6.619.


DOI:10.1136/ard.60.6.619
PMID:11350852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1753666/
Abstract

OBJECTIVE: To analyse the relations between the urinary levels of type II collagen C-telopeptide (CTX-II) and glucosyl-galactosyl pyridinoline (Glc-Gal-PYD)-two newly developed biochemical markers of type II collagen and synovial tissue destruction respectively-disease activity and the severity of joint destruction in patients with knee osteoarthritis (OA). The clinical performance of these two new markers was compared with that of a panel of other established biochemical markers of connective tissue metabolism. METHODS: The following biochemical markers were measured in a group of 67 patients with knee OA (mean age 64 years, median disease duration eight years ) and in 67 healthy controls: for bone, serum osteocalcin, serum and urinary C-telopeptide of type I collagen (CTX-I); for cartilage, urinary CTX-II, serum cartilage oligomeric matrix protein (COMP), and serum human cartilage glycoprotein 39 (YKL-40); for synovium, urinary Glc-Gal-PYD, serum type III collagen N-propeptide (PIIINP), serum hyaluronic acid (HA); and for inflammation, serum C reactive protein. Biochemical markers were correlated with pain and physical function (WOMAC index) and with quantitative radiographic evaluation of the joint space using the posteroanterior view of the knees flexed at 30 degrees. RESULTS: All bone turnover markers were decreased in patients with knee OA compared with controls (-36%, -38%, and -52%, p<0.0001 for serum osteocalcin, serum CTX-I and urinary CTX-I, respectively). Serum COMP (+16%, p=0.0004), urinary CTX-II (+25%, p=0.0009), urinary Glc-Gal-PYD (+18%, p=0.028), serum PIIINP (+33%, p<0.0001), and serum HA (+ 233%, p<0.0001) were increased. By univariate analyses, increased urinary Glc-Gal-PYD (r=0.41, p=0.002) and decreased serum osteocalcin (r=-0.30, p=0.025) were associated with a higher total WOMAC index. Increased urinary CTX-II (r=-0.40, p=0.0002) and Glc-Gal-PYD (r=-0.30, p=0.0046) and serum PIIINP (r=-0.29, p=0.0034) were the only markers which correlated with joint surface area. By multivariate analyses, urinary Glc-Gal-PYD and CTX-II were the most important predictors of the WOMAC index and joint damage, respectively. CONCLUSION: Knee OA appears to be characterised by a systemic decrease of bone turnover and increased cartilage and synovial tissue turnover. CTX-II, Glc-Gal-PYD, and PIIINP may be useful markers of disease severity in patients with knee OA.

摘要

相似文献

[1]
Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

Ann Rheum Dis. 2001-6

[2]
Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis.

Ann Rheum Dis. 2004-7

[3]
Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.

Arthritis Rheum. 2002-1

[4]
Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men.

Ann Rheum Dis. 2006-7

[5]
Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.

Rheumatol Int. 2018-2-2

[6]
Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.

J Rheumatol. 2005-4

[7]
The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects.

Rheumatol Int. 2012-7-21

[8]
Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.

Arthritis Rheum. 2002-10

[9]
Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.

Arthritis Res Ther. 2019-9-3

[10]
Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.

Arthritis Rheum. 2005-4

引用本文的文献

[1]
A sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage.

bioRxiv. 2025-7-31

[2]
A multi-tissue human knee single-cell atlas identifies that osteoarthritis reduces regenerative tissue stem cells while increasing inflammatory pain macrophages.

Commun Biol. 2025-8-2

[3]
Emerging Diagnostic Approaches for Musculoskeletal Disorders: Advances in Imaging, Biomarkers, and Clinical Assessment.

Diagnostics (Basel). 2025-6-27

[4]
Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease.

Diagnostics (Basel). 2025-6-3

[5]
Constructing a cross-tissue human knee single-cell atlas identified osteoarthritis reduces regenerative tissue stem cells while increasing inflammatory pain macrophages.

Res Sq. 2025-5-5

[6]
Unveiling a Novel Glioblastoma Deep Molecular Profiling: Insight into the Cancer Cell Differentiation-Related Mechanisms.

ACS Omega. 2025-3-8

[7]
A cross-sectional study on the assessment of COLL11A1, VEGF, and GDF5 gene polymorphisms in Turkish patients with primary knee osteoarthritis.

BMC Musculoskelet Disord. 2025-2-14

[8]
A framework of biomarkers for skeletal aging: a consensus statement by the Aging Biomarker Consortium.

Life Med. 2023-11-22

[9]
DNA methylation of bone morphogenetic protein 7 in leukocytes as a possible biomarker for hand osteoarthritis: A pilot study.

J Orthop Res. 2025-1

[10]
The role of obesity and adipose tissue dysfunction in osteoarthritis pain.

Nat Rev Rheumatol. 2024-9

本文引用的文献

[1]
COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage.

Connect Tissue Res. 1998

[2]
Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.

Arthritis Rheum. 2000-5

[3]
Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study.

J Rheumatol. 2000-4

[4]
Bone mineral density and bone turnover in patients with knee osteoarthritis compared with generalized osteoarthritis.

Calcif Tissue Int. 2000-5

[5]
Cross-sectional assessment of age-related bone loss in men: the MINOS study.

Bone. 2000-2

[6]
Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.

Arthritis Rheum. 1999-11

[7]
Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study.

J Bone Miner Res. 1999-9

[8]
Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Study of Osteoporotic Fractures Research Group.

Arthritis Rheum. 1999-7

[9]
Subchondral bone morphological and biochemical alterations in osteoarthritis.

Osteoarthritis Cartilage. 1999-5

[10]
Bone density and bone turnover in patients with osteoarthritis and osteoporosis.

J Rheumatol. 1999-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索